ResMed Inc. Officer & Director Michael J. Farrell Files Form 144 for $1.13M Proposed Sale
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Notice of Proposed Sale Company: RESMED INC (RMD) Insider: Farrell Michael J. (Officer, Director) Shares to Sell: 4,991 Common shares Approx. Value: $1,129,064.02 (~$226.22/share) Acquisition: Stock Option Exercise (Cash payment, 09/08/2026) Plan Adoption: 10/31/2024 (Rule 10b5-1) Broker: Fidelity Brokerage Services LLC
Comprehensive Analysis
Form 144 Analysis: ResMed Inc. (NYSE: RMD)
Summary
Officer and Director Michael J. Farrell filed a Form 144 notice on September 8, 2026, for the proposed sale of 4,991 shares of ResMed Inc. common stock, valued at approximately $1,129,064.02 (~$226.22 per share).
Key Details
- Securities to be Sold: 4,991 Common shares.
- Aggregate Market Value: $1,129,064.02.
- Origin of Shares: Acquired on September 8, 2026, via cash exercise of stock options from the issuer.
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on October 31, 2024.
- Historical Activity (Past 3 Months):
- August 7, 2026: 4,991 shares sold for $1,026,596.29
- July 7, 2026: 4,991 shares sold for $1,090,770.57
- June 8, 2026: 4,991 shares sold for $968,064.34
Significance Assessment
- Trading Significance: Low
- Context: The transaction represents a routine, pre-scheduled monthly option exercise and sale program under a long-standing Rule 10b5-1 plan established in October 2024. The 4,991 shares represent a negligible fraction of ResMed's 144,252,306 outstanding shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.